SCHEMBL171201

SCHEMBL171201

C[C@]1(n2cc(-c3cccc(OCc4ccccc4)c3)c3c(N)ncnc32)C[C@@H](CN2CCC2)C1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 20/20 0.71
INSR P06213 7/20 0.71
LYN P07948 5/20 0.71
LCK P06239 4/20 0.71
FGFR1 P11362 4/20 0.71
FLT4 P35916 4/20 0.71
KDR P35968 4/20 0.71
FLT3 P36888 4/20 0.71
SRC P12931 3/20 0.71
KIT P10721 3/20 0.71
FLT1 P17948 3/20 0.71
ERBB4 Q15303 3/20 0.71
RET P07949 3/20 0.71
ACVR1 Q04771 2/20 0.71
BTK Q06187 2/20 0.71
PDPK1 O15530 1/20 0.71
EGFR P00533 1/20 0.71
ERBB2 P04626 1/20 0.71
MET P08581 1/20 0.71
PDGFRB P09619 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17144883 0.89 IGF1R (0.71) IGF1RINSRLYNLCKFGFR1
SCHEMBL29561027 0.83 IGF1R (1.00) IGF1RINSRLYNLCKFGFR1
SCHEMBL1441421 0.83 IGF1R (1.00) IGF1RINSRLYNLCKFGFR1
SCHEMBL1987652 0.83 IGF1R (1.00) IGF1RINSRLYNLCKFGFR1
SCHEMBL94862 0.83 IGF1R (1.00) IGF1RINSRLYNLCKFGFR1
SCHEMBL1983472 0.81 IGF1R (1.00) IGF1RINSRLYNLCKFGFR1
SCHEMBL95142 0.81 IGF1R (1.00) IGF1RINSRLYNLCKFGFR1
SCHEMBL29356373 0.81 IGF1R (1.00) IGF1RINSRLYNLCKFGFR1
SCHEMBL1983470 0.81 IGF1R (1.00) IGF1RINSRLYNLCKFGFR1
SCHEMBL30631775 0.81 IGF1R (1.00) IGF1RINSRLYNLCKFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120058112-A1 ANTIBODIES MERCK SHARP & DOHME CORP. 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120058112-A1 ANTIBODIES IGF1R, EGFR, ERBB3 IGF1R 1/4885INSR 20/4885LYN 474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.